Invisible Orthodontics Market in North America 2023-2027

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	120 Pages	TechNavio	October, 2023	INF18272775

Best Price Guarantee
Price	from $2,500
Length	120 Pages
Publisher	TechNavio
Published Date	October, 2023
SKU	INF18272775

Invisible Orthodontics Market In North America 2023-2027

The invisible orthodontics market in North America is forecasted to grow by USD 1.05 bn during 2021-2026, accelerating at a CAGR of 12.1% during the forecast period. The report on the invisible orthodontics market in North America provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by an increasing number of dental conditions, an increasing number of product launches, and the increasing popularity of invisible orthodontics among teenagers.

Technavio's invisible orthodontics market in North America is segmented as below:

By Product

Clear aligners
Ceramic braces
Lingual braces

By Geographical Landscape

US
Canada
Mexico

This study identifies the digitization driven by CAD/CAMtechnology as one of the prime reasons driving the invisible orthodontics market in North America growth during the next few years. Also, complications associated with orthodontics and business strategies will lead to sizable demand in the market.

The report on the invisible orthodontics market in North America covers the following areas:

Invisible orthodontics market in North America sizing
Invisible orthodontics market in North America forecast
Invisible orthodontics market in North America industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading invisible orthodontics market in North America vendors that include 3M Co., Accutech Orthodontic Lab Inc., Align Technology Inc., American Orthodontics, Danaher Corp., DB Orthodontics Ltd., DENTSPLY SIRONA Inc., DynaFlex, Envista Holdings Corp., G and H Orthodontics, Great Lakes Dental Technologies, Henry Schein Inc., Ortho Caps GmbH, Rocky Mountain Orthodontics, SmileDirectClub Inc., Straumann Holding AG, and TP Orthodontics Inc.. Also, the invisible orthodontics market in North America analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Exhibit 01: Executive Summary - Chart on Market Overview; Exhibit 02: Executive Summary - Data Table on Market Overview; Exhibit 03: Executive Summary - Chart on Global Market Characteristics; Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape; Exhibit 05: Executive Summary - Chart on Market Segmentation by Application; Exhibit 06: Executive Summary - Chart on Market Segmentation by Technology; Exhibit 07: Executive Summary - Chart on Incremental Growth; Exhibit 08: Executive Summary - Data Table on Incremental Growth; Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Exhibit 10: Parent market; Exhibit 11: Market Characteristics
3 Market Sizing: 3.1 Market definition; Exhibit 12: Offerings of vendors included in the market definition; 3.2 Market segment analysis; Exhibit 13: Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global regenerative medicine market 2018 - 2022; Exhibit 18: Historic Market Size - Data Table on global regenerative medicine market 2018 - 2022 ($ million); 4.2 Application Segment Analysis 2018 - 2022; Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ million); 4.3 Technology Segment Analysis 2018 - 2022; Exhibit 20: Historic Market Size - Technology Segment 2018 - 2022 ($ million); 4.4 Geography Segment Analysis 2018 - 2022; Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country Segment Analysis 2018 - 2022; Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Exhibit 23: Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Application: 6.1 Market segments; Exhibit 30: Chart on Application - Market share 2023-2028 (%); Exhibit 31: Data Table on Application - Market share 2023-2028 (%); 6.2 Comparison by Application; Exhibit 32: Chart on Comparison by Application; Exhibit 33: Data Table on Comparison by Application; 6.3 Oncology - Market size and forecast 2023-2028; Exhibit 34: Chart on Oncology - Market size and forecast 2023-2028 ($ million); Exhibit 35: Data Table on Oncology - Market size and forecast 2023-2028 ($ million); Exhibit 36: Chart on Oncology - Year-over-year growth 2023-2028 (%); Exhibit 37: Data Table on Oncology - Year-over-year growth 2023-2028 (%); 6.4 Musculoskeletal - Market size and forecast 2023-2028; Exhibit 38: Chart on Musculoskeletal - Market size and forecast 2023-2028 ($ million); Exhibit 39: Data Table on Musculoskeletal - Market size and forecast 2023-2028 ($ million); Exhibit 40: Chart on Musculoskeletal - Year-over-year growth 2023-2028 (%); Exhibit 41: Data Table on Musculoskeletal - Year-over-year growth 2023-2028 (%); 6.5 Dermatology - Market size and forecast 2023-2028; Exhibit 42: Chart on Dermatology - Market size and forecast 2023-2028 ($ million); Exhibit 43: Data Table on Dermatology - Market size and forecast 2023-2028 ($ million); Exhibit 44: Chart on Dermatology - Year-over-year growth 2023-2028 (%); Exhibit 45: Data Table on Dermatology - Year-over-year growth 2023-2028 (%); 6.6 Immunology and inflammation and others - Market size and forecast 2023-2028; Exhibit 46: Chart on Immunology and inflammation and others - Market size and forecast 2023-2028 ($ million); Exhibit 47: Data Table on Immunology and inflammation and others - Market size and forecast 2023-2028 ($ million); Exhibit 48: Chart on Immunology and inflammation and others - Year-over-year growth 2023-2028 (%); Exhibit 49: Data Table on Immunology and inflammation and others - Year-over-year growth 2023-2028 (%); 6.7 Market opportunity by Application; Exhibit 50: Market opportunity by Application ($ million); Exhibit 51: Data Table on Market opportunity by Application ($ million)
7 Market Segmentation by Technology: 7.1 Market segments; Exhibit 52: Chart on Technology - Market share 2023-2028 (%); Exhibit 53: Data Table on Technology - Market share 2023-2028 (%); 7.2 Comparison by Technology; Exhibit 54: Chart on Comparison by Technology; Exhibit 55: Data Table on Comparison by Technology; 7.3 Cell and tissue-based - Market size and forecast 2023-2028; Exhibit 56: Chart on Cell and tissue-based - Market size and forecast 2023-2028 ($ million); Exhibit 57: Data Table on Cell and tissue-based - Market size and forecast 2023-2028 ($ million); Exhibit 58: Chart on Cell and tissue-based - Year-over-year growth 2023-2028 (%); Exhibit 59: Data Table on Cell and tissue-based - Year-over-year growth 2023-2028 (%); 7.4 Gene therapy - Market size and forecast 2023-2028; Exhibit 60: Chart on Gene therapy - Market size and forecast 2023-2028 ($ million); Exhibit 61: Data Table on Gene therapy - Market size and forecast 2023-2028 ($ million); Exhibit 62: Chart on Gene therapy - Year-over-year growth 2023-2028 (%); Exhibit 63: Data Table on Gene therapy - Year-over-year growth 2023-2028 (%); 7.5 Market opportunity by Technology; Exhibit 64: Market opportunity by Technology ($ million); Exhibit 65: Data Table on Market opportunity by Technology ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Exhibit 69: Chart on Geographic comparison; Exhibit 70: Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%); Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 Germany - Market size and forecast 2023-2028; Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.9 Japan - Market size and forecast 2023-2028; Exhibit 95: Chart on Japan - Market size and forecast 2023-2028 ($ million); Exhibit 96: Data Table on Japan - Market size and forecast 2023-2028 ($ million); Exhibit 97: Chart on Japan - Year-over-year growth 2023-2028 (%); Exhibit 98: Data Table on Japan - Year-over-year growth 2023-2028 (%); 9.10 UK - Market size and forecast 2023-2028; Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%); 9.11 China - Market size and forecast 2023-2028; Exhibit 103: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibit 104: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibit 105: Chart on China - Year-over-year growth 2023-2028 (%); Exhibit 106: Data Table on China - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Exhibit 107: Market opportunity By Geographical Landscape ($ million); Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Exhibit 109: Impact of drivers and challenges in 2023 and 2028; 10.4 Market trends
11 Vendor Landscape: 11.1 Overview; 11.2 Vendor landscape; Exhibit 110: Overview on Criticality of inputs and Factors of differentiation; 11.3 Landscape disruption; Exhibit 111: Overview on factors of disruption; 11.4 Industry risks; Exhibit 112: Impact of key risks on business
12 Vendor Analysis: 12.1 Vendors covered; Exhibit 113: Vendors covered; 12.2 Market positioning of vendors; Exhibit 114: Matrix on vendor position and classification; 12.3 AbbVie Inc.; Exhibit 115: AbbVie Inc. - Overview; Exhibit 116: AbbVie Inc. - Product / Service; Exhibit 117: AbbVie Inc. - Key news; Exhibit 118: AbbVie Inc. - Key offerings; 12.4 Amgen Inc.; Exhibit 119: Amgen Inc. - Overview; Exhibit 120: Amgen Inc. - Product / Service; Exhibit 121: Amgen Inc. - Key offerings; 12.5 Baxter International Inc.; Exhibit 122: Baxter International Inc. - Overview; Exhibit 123: Baxter International Inc. - Business segments; Exhibit 124: Baxter International Inc. - Key news; Exhibit 125: Baxter International Inc. - Key offerings; Exhibit 126: Baxter International Inc. - Segment focus; 12.6 Becton Dickinson and Co.; Exhibit 127: Becton Dickinson and Co. - Overview; Exhibit 128: Becton Dickinson and Co. - Business segments; Exhibit 129: Becton Dickinson and Co. - Key news; Exhibit 130: Becton Dickinson and Co. - Key offerings; Exhibit 131: Becton Dickinson and Co. - Segment focus; 12.7 Cook Group Inc.; Exhibit 132: Cook Group Inc. - Overview; Exhibit 133: Cook Group Inc. - Product / Service; Exhibit 134: Cook Group Inc. - Key offerings; 12.8 Integra Lifesciences Corp.; Exhibit 135: Integra Lifesciences Corp. - Overview; Exhibit 136: Integra Lifesciences Corp. - Business segments; Exhibit 137: Integra Lifesciences Corp. - Key news; Exhibit 138: Integra Lifesciences Corp. - Key offerings; Exhibit 139: Integra Lifesciences Corp. - Segment focus; 12.9 Medtronic Plc; Exhibit 140: Medtronic Plc - Overview; Exhibit 141: Medtronic Plc - Business segments; Exhibit 142: Medtronic Plc - Key news; Exhibit 143: Medtronic Plc - Key offerings; Exhibit 144: Medtronic Plc - Segment focus; 12.10 Merck and Co. Inc.; Exhibit 145: Merck and Co. Inc. - Overview; Exhibit 146: Merck and Co. Inc. - Business segments; Exhibit 147: Merck and Co. Inc. - Key news; Exhibit 148: Merck and Co. Inc. - Key offerings; Exhibit 149: Merck and Co. Inc. - Segment focus; 12.11 MiMedx Group Inc.; Exhibit 150: MiMedx Group Inc. - Overview; Exhibit 151: MiMedx Group Inc. - Business segments; Exhibit 152: MiMedx Group Inc. - Key news; Exhibit 153: MiMedx Group Inc. - Key offerings; Exhibit 154: MiMedx Group Inc. - Segment focus; 12.12 Novartis AG; Exhibit 155: Novartis AG - Overview; Exhibit 156: Novartis AG - Business segments; Exhibit 157: Novartis AG - Key offerings; Exhibit 158: Novartis AG - Segment focus; 12.13 Nuvasive Inc.; Exhibit 159: Nuvasive Inc. - Overview; Exhibit 160: Nuvasive Inc. - Business segments; Exhibit 161: Nuvasive Inc. - Key news; Exhibit 162: Nuvasive Inc. - Key offerings; Exhibit 163: Nuvasive Inc. - Segment focus; 12.14 Organogenesis Holdings Inc.; Exhibit 164: Organogenesis Holdings Inc. - Overview; Exhibit 165: Organogenesis Holdings Inc. - Product / Service; Exhibit 166: Organogenesis Holdings Inc. - Key offerings; 12.15 Smith and Nephew plc; Exhibit 167: Smith and Nephew plc - Overview; Exhibit 168: Smith and Nephew plc - Business segments; Exhibit 169: Smith and Nephew plc - Key news; Exhibit 170: Smith and Nephew plc - Key offerings; Exhibit 171: Smith and Nephew plc - Segment focus; 12.16 Thermo Fisher Scientific Inc.; Exhibit 172: Thermo Fisher Scientific Inc. - Overview; Exhibit 173: Thermo Fisher Scientific Inc. - Business segments; Exhibit 174: Thermo Fisher Scientific Inc. - Key news; Exhibit 175: Thermo Fisher Scientific Inc. - Key offerings; Exhibit 176: Thermo Fisher Scientific Inc. - Segment focus; 12.17 Vericel Corp.; Exhibit 177: Vericel Corp. - Overview; Exhibit 178: Vericel Corp. - Product / Service; Exhibit 179: Vericel Corp. - Key news; Exhibit 180: Vericel Corp. - Key offerings
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Exhibit 181: Inclusions checklist; Exhibit 182: Exclusions checklist; 13.3 Currency conversion rates for US$; Exhibit 183: Currency conversion rates for US$; 13.4 Research methodology; Exhibit 184: Research methodology; Exhibit 185: Validation techniques employed for market sizing; Exhibit 186: Information sources; 13.5 List of abbreviations; Exhibit 187: List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Application; Exhibits6: Executive Summary - Chart on Market Segmentation by Technology; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Vendor Market Positioning; Exhibits10: Parent market; Exhibits11: Market Characteristics; Exhibits12: Offerings of vendors included in the market definition; Exhibits13: Market segments; Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits18: Historic Market Size - Data Table on global regenerative medicine market 2018 - 2022 ($ million); Exhibits19: Historic Market Size - Application Segment 2018 - 2022 ($ million); Exhibits20: Historic Market Size - Technology Segment 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits23: Five forces analysis - Comparison between 2023 and 2028; Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits29: Chart on Market condition - Five forces 2023 and 2028; Exhibits30: Chart on Application - Market share 2023-2028 (%); Exhibits31: Data Table on Application - Market share 2023-2028 (%); Exhibits32: Chart on Comparison by Application; Exhibits33: Data Table on Comparison by Application; Exhibits34: Chart on Oncology - Market size and forecast 2023-2028 ($ million); Exhibits35: Data Table on Oncology - Market size and forecast 2023-2028 ($ million); Exhibits36: Chart on Oncology - Year-over-year growth 2023-2028 (%); Exhibits37: Data Table on Oncology - Year-over-year growth 2023-2028 (%); Exhibits38: Chart on Musculoskeletal - Market size and forecast 2023-2028 ($ million); Exhibits39: Data Table on Musculoskeletal - Market size and forecast 2023-2028 ($ million); Exhibits40: Chart on Musculoskeletal - Year-over-year growth 2023-2028 (%); Exhibits41: Data Table on Musculoskeletal - Year-over-year growth 2023-2028 (%); Exhibits42: Chart on Dermatology - Market size and forecast 2023-2028 ($ million); Exhibits43: Data Table on Dermatology - Market size and forecast 2023-2028 ($ million); Exhibits44: Chart on Dermatology - Year-over-year growth 2023-2028 (%); Exhibits45: Data Table on Dermatology - Year-over-year growth 2023-2028 (%); Exhibits46: Chart on Immunology and inflammation and others - Market size and forecast 2023-2028 ($ million); Exhibits47: Data Table on Immunology and inflammation and others - Market size and forecast 2023-2028 ($ million); Exhibits48: Chart on Immunology and inflammation and others - Year-over-year growth 2023-2028 (%); Exhibits49: Data Table on Immunology and inflammation and others - Year-over-year growth 2023-2028 (%); Exhibits50: Market opportunity by Application ($ million); Exhibits51: Data Table on Market opportunity by Application ($ million); Exhibits52: Chart on Technology - Market share 2023-2028 (%); Exhibits53: Data Table on Technology - Market share 2023-2028 (%); Exhibits54: Chart on Comparison by Technology; Exhibits55: Data Table on Comparison by Technology; Exhibits56: Chart on Cell and tissue-based - Market size and forecast 2023-2028 ($ million); Exhibits57: Data Table on Cell and tissue-based - Market size and forecast 2023-2028 ($ million); Exhibits58: Chart on Cell and tissue-based - Year-over-year growth 2023-2028 (%); Exhibits59: Data Table on Cell and tissue-based - Year-over-year growth 2023-2028 (%); Exhibits60: Chart on Gene therapy - Market size and forecast 2023-2028 ($ million); Exhibits61: Data Table on Gene therapy - Market size and forecast 2023-2028 ($ million); Exhibits62: Chart on Gene therapy - Year-over-year growth 2023-2028 (%); Exhibits63: Data Table on Gene therapy - Year-over-year growth 2023-2028 (%); Exhibits64: Market opportunity by Technology ($ million); Exhibits65: Data Table on Market opportunity by Technology ($ million); Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits67: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits68: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits69: Chart on Geographic comparison; Exhibits70: Data Table on Geographic comparison; Exhibits71: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits72: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits73: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits74: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits75: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits76: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits77: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits78: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits79: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits80: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits81: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits82: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits87: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits88: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits89: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits90: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits91: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits92: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits93: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits94: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits95: Chart on Japan - Market size and forecast 2023-2028 ($ million); Exhibits96: Data Table on Japan - Market size and forecast 2023-2028 ($ million); Exhibits97: Chart on Japan - Year-over-year growth 2023-2028 (%); Exhibits98: Data Table on Japan - Year-over-year growth 2023-2028 (%); Exhibits99: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits100: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits101: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits102: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits103: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits104: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits105: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits106: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits107: Market opportunity By Geographical Landscape ($ million); Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits109: Impact of drivers and challenges in 2023 and 2028; Exhibits110: Overview on Criticality of inputs and Factors of differentiation; Exhibits111: Overview on factors of disruption; Exhibits112: Impact of key risks on business; Exhibits113: Vendors covered; Exhibits114: Matrix on vendor position and classification; Exhibits115: AbbVie Inc. - Overview; Exhibits116: AbbVie Inc. - Product / Service; Exhibits117: AbbVie Inc. - Key news; Exhibits118: AbbVie Inc. - Key offerings; Exhibits119: Amgen Inc. - Overview; Exhibits120: Amgen Inc. - Product / Service; Exhibits121: Amgen Inc. - Key offerings; Exhibits122: Baxter International Inc. - Overview; Exhibits123: Baxter International Inc. - Business segments; Exhibits124: Baxter International Inc. - Key news; Exhibits125: Baxter International Inc. - Key offerings; Exhibits126: Baxter International Inc. - Segment focus; Exhibits127: Becton Dickinson and Co. - Overview; Exhibits128: Becton Dickinson and Co. - Business segments; Exhibits129: Becton Dickinson and Co. - Key news; Exhibits130: Becton Dickinson and Co. - Key offerings; Exhibits131: Becton Dickinson and Co. - Segment focus; Exhibits132: Cook Group Inc. - Overview; Exhibits133: Cook Group Inc. - Product / Service; Exhibits134: Cook Group Inc. - Key offerings; Exhibits135: Integra Lifesciences Corp. - Overview; Exhibits136: Integra Lifesciences Corp. - Business segments; Exhibits137: Integra Lifesciences Corp. - Key news; Exhibits138: Integra Lifesciences Corp. - Key offerings; Exhibits139: Integra Lifesciences Corp. - Segment focus; Exhibits140: Medtronic Plc - Overview; Exhibits141: Medtronic Plc - Business segments; Exhibits142: Medtronic Plc - Key news; Exhibits143: Medtronic Plc - Key offerings; Exhibits144: Medtronic Plc - Segment focus; Exhibits145: Merck and Co. Inc. - Overview; Exhibits146: Merck and Co. Inc. - Business segments; Exhibits147: Merck and Co. Inc. - Key news; Exhibits148: Merck and Co. Inc. - Key offerings; Exhibits149: Merck and Co. Inc. - Segment focus; Exhibits150: MiMedx Group Inc. - Overview; Exhibits151: MiMedx Group Inc. - Business segments; Exhibits152: MiMedx Group Inc. - Key news; Exhibits153: MiMedx Group Inc. - Key offerings; Exhibits154: MiMedx Group Inc. - Segment focus; Exhibits155: Novartis AG - Overview; Exhibits156: Novartis AG - Business segments; Exhibits157: Novartis AG - Key offerings; Exhibits158: Novartis AG - Segment focus; Exhibits159: Nuvasive Inc. - Overview; Exhibits160: Nuvasive Inc. - Business segments; Exhibits161: Nuvasive Inc. - Key news; Exhibits162: Nuvasive Inc. - Key offerings; Exhibits163: Nuvasive Inc. - Segment focus; Exhibits164: Organogenesis Holdings Inc. - Overview; Exhibits165: Organogenesis Holdings Inc. - Product / Service; Exhibits166: Organogenesis Holdings Inc. - Key offerings; Exhibits167: Smith and Nephew plc - Overview; Exhibits168: Smith and Nephew plc - Business segments; Exhibits169: Smith and Nephew plc - Key news; Exhibits170: Smith and Nephew plc - Key offerings; Exhibits171: Smith and Nephew plc - Segment focus; Exhibits172: Thermo Fisher Scientific Inc. - Overview; Exhibits173: Thermo Fisher Scientific Inc. - Business segments; Exhibits174: Thermo Fisher Scientific Inc. - Key news; Exhibits175: Thermo Fisher Scientific Inc. - Key offerings; Exhibits176: Thermo Fisher Scientific Inc. - Segment focus; Exhibits177: Vericel Corp. - Overview; Exhibits178: Vericel Corp. - Product / Service; Exhibits179: Vericel Corp. - Key news; Exhibits180: Vericel Corp. - Key offerings; Exhibits181: Inclusions checklist; Exhibits182: Exclusions checklist; Exhibits183: Currency conversion rates for US$; Exhibits184: Research methodology; Exhibits185: Validation techniques employed for market sizing; Exhibits186: Information sources; Exhibits187: List of abbreviations